ID: h-e031e9fde6
Hypothesis
HBOT at 1.5 ATA for 90 days restores BBB integrity by upregulating claudin-5 and reducing pericyte degeneration
HBOT promotes pericyte survival via PDGF-BB/PDGFR-β signaling and upregulates claudin-5 transcription through HIF-2α to repair BBB breakdown in AD.
EvidencePending (0%)📖 0 cit🗣 1 debates✓ 3 support✗ 3 oppose
✓ All Quality Gates Passed
🧪 Overview
HBOT promotes pericyte survival via PDGF-BB/PDGFR-β signaling and upregulates claudin-5 transcription through HIF-2α to repair BBB breakdown in AD. However, tight-junction upregulation is not equivalent to restored BBB function; endothelial transcytosis, basement membrane changes, and astrocytic endfeet dysfunction also contribute to BBB failure. The 90-day duration claim is clinically impractical.
🧬 Mechanism
🧬 Curated Mechanism Pathway
Curated pathway from expert analysis
flowchart TD
A["HBOT 1.5 ATA<br/>90 days"]
B["HIF-2a<br/>Upregulation"]
C["Claudin-5<br/>Transcription Increase"]
D["Pericyte<br/>Survival via PDGF-BB"]
E["Tight Junction<br/>Repair"]
F["BBB Integrity<br/>Restoration"]
A --> B
B --> C
A --> D
D --> C
C --> E
E --> F
style A fill:#1b5e20,stroke:#a5d6a7,color:#a5d6a7
style B fill:#004d40,stroke:#80cbc4,color:#80cbc4
style F fill:#1b5e20,stroke:#a5d6a7,color:#a5d6a7⚖️ Evidence
⚖️ Evidence Matrix3 supports3 contradicts
Contradicts
Claudin-5 increases in diabetic models may not translate to chronic aged AD vasculopathy
📖 Linked Papers
No linked papers recorded for this hypothesis yet.
🏥 Translation
🧬 3D Protein Structure — CLDN5
No curated PDB or AlphaFold mapping for CLDN5 yet. Search RCSB →
🧠 GTEx v10 Brain ExpressionJSON
Median TPM across 13 brain regions for CLDN5 from GTEx v10.
💉 Clinical Trials
No clinical trials data linked to this hypothesis yet.
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for CLDN5.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
💰 Estimated Development
Cost
$0
Timeline
—
🏆 Tournament
🏆 Arenas / Elo
No arena matches recorded yet. Browse Arenas →
📊 Market Indicators
7d Trend
↔
Stable
7d Momentum
▲ 0.0%
Volatility
Low
0.0151
Events (7d)
1
Price History
▲4.8%💾 Resource Usage
LLM Tokens
11,804
$0.0354
Total Cost
$0.0354
🔮 Predictions
🔎 Predictions vs Observations2 predictions · 0 with recorded observations
| Prediction | Predicted | Observed | Status | Conf |
|---|---|---|---|---|
| IF 5xFAD transgenic mice undergo HBOT at 1.5 ATA for 90 days, THEN pericyte coverage of cerebral microvessels will increase by at least 30% and PDGFR-β expression will upregulate, restoring BBB leakag | Pericyte coverage (NG2+/PDGFR-β+ cells per vessel length) increases by 30%+ and BBB permeability (Evans Blue or sodium fluorescein extravasation) decreases to w | — no observation — | pending | 0.55 |
| IF patients with confirmed Alzheimer's disease receive HBOT at 1.5 ATA for 90 consecutive days (60 sessions), THEN cerebrospinal fluid claudin-5 protein levels will increase by at least 25% relative t | CSF claudin-5 concentration increases by 25-40% post-intervention compared to pre-HBOT baseline, detectable via ELISA | — no observation — | pending | 0.45 |
🔮 Falsifiable Predictions (2)
pendingconf 55%
IF 5xFAD transgenic mice undergo HBOT at 1.5 ATA for 90 days, THEN pericyte coverage of cerebral microvessels will increase by at least 30% and PDGFR-β expression will upregulate, restoring BBB leakage to wild-type levels.
Predicted outcome: Pericyte coverage (NG2+/PDGFR-β+ cells per vessel length) increases by 30%+ and BBB permeability (Evans Blue or sodium fluorescein extravasation) decr
Falsification: Pericyte coverage shows no change or decreases; BBB permeability remains elevated (>2 SD above WT) despite 90-day HBOT protocol
pendingconf 45%
IF patients with confirmed Alzheimer's disease receive HBOT at 1.5 ATA for 90 consecutive days (60 sessions), THEN cerebrospinal fluid claudin-5 protein levels will increase by at least 25% relative to baseline measurements.
Predicted outcome: CSF claudin-5 concentration increases by 25-40% post-intervention compared to pre-HBOT baseline, detectable via ELISA
Falsification: CSF claudin-5 levels show no statistically significant change (p > 0.05) or decrease relative to sham-treated controls after 90-day protocol
▸Metadatasource: v1_phase_c_backfill · origin_type: debate_synthesizer
| source | v1_phase_c_backfill |
| origin_type | debate_synthesizer |
| _schema_version | 1 |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.